GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3D Medicines Inc (HKSE:01244) » Definitions » FCF Yield %

3D Medicines (HKSE:01244) FCF Yield % : -10.14 (As of Jun. 05, 2024)


View and export this data going back to 2022. Start your Free Trial

What is 3D Medicines FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, 3D Medicines's Trailing 12-Month Free Cash Flow is HK$-164.9 Mil, and Market Cap is HK$1,626.5 Mil. Therefore, 3D Medicines's FCF Yield % for today is -10.14%.

The historical rank and industry rank for 3D Medicines's FCF Yield % or its related term are showing as below:

HKSE:01244' s FCF Yield % Range Over the Past 10 Years
Min: -111.91   Med: -11.92   Max: -4.89
Current: -10.14

During the past 4 years, the highest FCF Yield % of 3D Medicines was -4.89%. The lowest was -111.91%. And the median was -11.92%.

HKSE:01244's FCF Yield % is ranked better than
57.37% of 1553 companies
in the Biotechnology industry
Industry Median: -14.22 vs HKSE:01244: -10.14

3D Medicines's FCF Margin % for the quarter that ended in Dec. 2023 was 8.13%.

3D Medicines FCF Yield % Historical Data

The historical data trend for 3D Medicines's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3D Medicines FCF Yield % Chart

3D Medicines Annual Data
Trend Dec20 Dec21 Dec22 Dec23
FCF Yield %
- - -3.42 -8.36

3D Medicines Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
FCF Yield % Get a 7-Day Free Trial - - -4.71 -1.54 2.54

Competitive Comparison of 3D Medicines's FCF Yield %

For the Biotechnology subindustry, 3D Medicines's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

3D Medicines's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3D Medicines's FCF Yield % distribution charts can be found below:

* The bar in red indicates where 3D Medicines's FCF Yield % falls into.


3D Medicines FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

3D Medicines's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-164.873 / 1972.70148
=-8.36%

3D Medicines's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=25.1 * 2 / 1972.70148
=2.54%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

3D Medicines FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

3D Medicines FCF Yield % Related Terms

Thank you for viewing the detailed overview of 3D Medicines's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

3D Medicines (HKSE:01244) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3D Medicines Inc (HKSE:01244) » Definitions » FCF Yield %
Comparable Companies
HKSE:02616 HKSE:01873 HKSE:06622 HKSE:01167 HKSE:06978 HKSE:02496 HKSE:01672 HKSE:02181 HKSE:02256 HKSE:02137 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
No. 3 and No. 5, Laiyang Road, Shandong, Qingdao, CHN
Website
https://www.3d-medicines.com
3D Medicines Inc is a commercial-stage biopharmaceutical company that researches, develops, and commercialization of drugs in the field of managing cancer as a chronic disease. It develops differentiated immuno-oncology drugs, helping cancer patients live with prolonged survival time and quality of life.
Executives
Gong Zhaolong 2101 Beneficial owner
Zhu Pai 2101 Beneficial owner
Dragon Prosper Holdings Limited 2101 Beneficial owner
Simcere Pharmaceutical Group Limited 2101 Beneficial owner
Gong Zhaolong 2501 Other
Immunal Medixin Us Limited 2101 Beneficial owner
Kastle Limited
Shanghai Zhenlu Enterprise Management Consulting Partnership (limited Partnership) 2101 Beneficial owner
Shenzhen Efung Holding Co., Ltd. 2201 Interest of corporation controlled by you
Shenzhen Efung Investment Management Enterprise (l.p.) 2201 Interest of corporation controlled by you
Shenzhen Efung Ruishi Investment Enterprise (limited Partnership) 2201 Interest of corporation controlled by you
Zhu Jinqiao 2103 Interests held jointly with another person

3D Medicines (HKSE:01244) Headlines

No Headlines